期刊文献+
共找到1,324篇文章
< 1 2 67 >
每页显示 20 50 100
Early antiplatelet therapy used for acute ischemic stroke and intracranial hemorrhage 被引量:1
1
作者 Venkata Buddhavarapu Rahul Kashyap Salim Surani 《World Journal of Clinical Cases》 SCIE 2024年第4期677-680,共4页
In this editorial we comment on the article published by Zhang et al in the recent issue of World Journal of Clinical Cases.We evaluate their claims on the benefit of use of Aspirin in the early management of patients... In this editorial we comment on the article published by Zhang et al in the recent issue of World Journal of Clinical Cases.We evaluate their claims on the benefit of use of Aspirin in the early management of patients with ischemic stroke.We also comment on their contention of using aspirin in the early management of patients with intracranial hemorrhage,a practice not seen in modern medicine.Large clinical trials such as the International Stroke Trial and the Chinese Acute Stroke Trial have shown the benefit of Aspirin use within 48 h of patients with Acute Ischemic Stroke.The findings were corroborated in the open-label trial performed by Zhang et al in a smaller sample group of 25 patients where they showed improvement in functional scores at 90 days without an increase in adverse events.As such,this intervention is also recommended by the American Heart Association stroke guidelines from 2021.With regard to Intracranial hemorrhage,traditional practice has been to discontinue or avoid antiplatelet therapy in these patient groups.However,no studies have been done to evaluate this management strategy that is more borne out of the mechanism behind Aspirin’s effect on the coagulation pathway.Zhang et al evaluate the benefits of Aspirin on patients with low-volume intracranial hemorrhage,i.e.,less than 30 mL on computed tomo-graphy imaging,and show no increase in mortality.The caveat of this finding is that all outcomes were pooled into one group for results,and the number of patients was low.While more studies with larger patient groups are required,the data from Zhang et al suggests that patients with small-volume intracranial hemorrhages may benefit from Aspirin administration in the acute phase of management. 展开更多
关键词 ASPIRIN Ischemic stroke intracranial hemorrhage CVA Antiplatelet therapy
下载PDF
Prognostic value of intracranial pressure monitoring for the management of hypertensive intracerebral hemorrhage following minimally invasive surgery 被引量:45
2
作者 Xiao-ru Che Yong-jie Wang Hai-yan Zheng 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2020年第3期169-173,共5页
BACKGROUND:The incidence of hypertensive intracerebral hemorrhage(HICH)has been increasing during the recent years in low-and middle-income countries.With high mortality and morbidity rates,it brings huge burden to th... BACKGROUND:The incidence of hypertensive intracerebral hemorrhage(HICH)has been increasing during the recent years in low-and middle-income countries.With high mortality and morbidity rates,it brings huge burden to the families.It lacks evidence regarding the application of intracranial pressure(ICP)monitoring in HICH.In the current study,the authors aimed to evaluate whether ICP monitoring could make any difference on the prognosis of HICH patients after minimally invasive surgery.METHODS:A retrospective review of 116 HICH patients admitted to the Second Affiliated Hospital of Zhejiang University School of Medicine,between 2014 and 2016,was performed.The effects of ICP monitoring on 6-month mortality and favorable outcomes were evaluated by univariate and logistic regression analysis.RESULTS:ICP monitors were inserted into 50 patients.Patients with ICP monitoring had a significantly better outcome(P<0.05).The average in-hospital duration in patients with ICP monitoring was shorter than that in the patients without ICP monitoring(16.68 days vs.20.47 days,P<0.05).Mortality rates between ICP monitoring and no ICP monitoring did not differ significantly(16.0%vs.15.1%,P=0.901).On univariate analysis,age,Glasgow Coma Scale(GCS)on admission and presence of ICP monitor were independent predictors of 6-month favorable outcomes.CONCLUSION:ICP monitoring is associated with a better 6-month functional outcome compared with no ICP monitoring.Future study is still needed to confirm our results and elucidate which subgroup of HICH patients will benefit most from the minimally invasive surgical intervention and ICP monitoring. 展开更多
关键词 hypertensive INTRACEREBRAL hemorrhage intracranial pressure MINIMALLY INVASIVE surgery
下载PDF
Effect of minimally invasive intracranial hematoma drainage on inflammatory factors, serum ferritin and serum P substance in patients with hypertensive cerebral hemorrhage 被引量:2
3
作者 Sheng-De Nong Ming-Xiong Lu +3 位作者 Ting-Yang Li Hai-Chang Huang Jing Ye Chao-JueHuang 《Journal of Hainan Medical University》 2017年第1期113-116,共4页
Objective:To study the effect of minimally invasive intracranial hematoma drainage on inflammatory factors, serum ferritin and serum P substance in patients with hypertensive cerebral hemorrhage.Methods:92 cases of hy... Objective:To study the effect of minimally invasive intracranial hematoma drainage on inflammatory factors, serum ferritin and serum P substance in patients with hypertensive cerebral hemorrhage.Methods:92 cases of hypertensive cerebral hemorrhage patients in our hospital were selected and randomly divided into 2 groups: minimally invasive group (51 cases) and routine group (41 cases). Minimally invasive intracranial hematoma drainage was performed on the minimally invasive group. Bone flap decompression or small bone window craniotomy were used in the routine group. Tumor necrosis factorα (TNF-α), interleukin-6 (IL-6), high sensitive C reactive protein (hs-CRP) and serum protein (SF), serum substance P (SP) in the 2 groups were detected before treatment and 2 weeks after treatment.Results: The comparison of TNF-α, IL-6, hs-CRP, SP, and SF in the two groups before treatment was not statistically significant (P>0.05). TNF-α, IL-6, hs-CRP and SF in both groups after treatment significantly decreased, compared with that before treatment (P<0.01,P<0.05). TNF-α, IL-6, and SF in minimally invasive group decreased more significantly than that in routine group (P<0.01);The comparison of SP in the two groups after treatment significantly increased compared with that before treatment (P<0.01,P<0.05). SP in minimally invasive group increased more significantly than that in routine group (P<0.05).Conclusions:Compared with bone flap decompression or small bone window craniotomy, minimally invasive intracranial hematoma drainage can inhibit inflammatory reaction, reduce the degree of nerve damage and alleviate clinical symptoms more effectively. 展开更多
关键词 MINIMALLY invasive intracranial HEMATOMA drainage hypertensive cerebral hemorrhage Inflammatory factor SERUM FERRITIN SERUM P substance
下载PDF
TCD value for evaluating the intracranial hypertension and nerve injury in patients with hypertensive cerebral hemorrhage
4
作者 Li Guo Zhi-Yong Li Quan-Quan Yang 《Journal of Hainan Medical University》 2018年第1期137-140,共4页
Objective: To evaluate the assessment of intracranial hypertension and nerve injury in patients with hypertensive cerebral hemorrhage by transcranial Doppler (TCD). Methods: The patients who were hospitalized for hype... Objective: To evaluate the assessment of intracranial hypertension and nerve injury in patients with hypertensive cerebral hemorrhage by transcranial Doppler (TCD). Methods: The patients who were hospitalized for hypertensive cerebral hemorrhage between August 2014 and February 2017 were selected as the cerebral hemorrhage group and healthy subjects who received physical examination during the same period were selected as the control group;TCD was used to determine the PI of affected-side and unaffected-side middle cerebral artery in cerebral hemorrhage group and lumbar puncture was done to measure intracranial pressure. The serum was collected from the two groups to detect the levels of inflammatory cytokines and nerve injury markers. Results: PI level in affected-side middle cerebral artery of cerebral hemorrhage group was significantly higher than that in the unaffected-side and positively correlated with intracranial pressure level;serum IL-1β, TNF-α, ICAM-1, MMP9, YKL-40, Asp, Glu, NPY, NSE and GFAP levels of cerebral hemorrhage group were significantly higher than those of control group, and serum IL-1β, TNF-α, ICAM-1, MMP9, YKL-40, Asp, Glu, NPY, NSE and GFAP levels of cerebral hemorrhage group of patients with high PI level were significantly higher than those of cerebral hemorrhage group of patients with low PI level. Conclusion: TCD parameters can evaluate the degree of intracranial pressure increase and nerve injury in patients with hypertensive cerebral hemorrhage. 展开更多
关键词 hypertensive cerebral hemorrhage TRANSCRANIAL Doppler intracranial pressure INFLAMMATORY response NERVE injury
下载PDF
Therapeutic effect of minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage and TCD evaluation
5
作者 Zi-Hao Zhang Wen-Liang Zhang +7 位作者 Ye Liu Zhi-Bao Wu Liang Liu Pu Gao Ning Gan Shu-Zhang An Hong-Chuan Guo Min Zhou 《Journal of Hainan Medical University》 2017年第6期135-138,共4页
Objective:To explore the therapeutic effect of minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage and the value of dynamic TCD monitoring in predicting the neurolo... Objective:To explore the therapeutic effect of minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage and the value of dynamic TCD monitoring in predicting the neurological function recovery.Methods: A total of 70 patients with hypertensive cerebral hemorrhage who were admitted in our hospital were included in the study and divided into the minimally invasive group and conservative group with 35 cases in each group according to different treatment protocols. The patients in the two groups were given drug conservative treatments. On this basis, the patients in the minimally invasive group were given urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle. TCD was performed before treatment, 1 d, 5 d, 10 d, and 21 d after treatment. The hematoma and edema volume was calculated. NIHSS was used to evaluate the neurological function recovery.Results: Vs, Vd, and Vm after treatment in the minimally invasive group were significantly elevated, while PI was significantly reduced. Vs, Vd, and Vm after treatment in the conservative group were reduced first and elevated later, while PI was elevated first and reduced later, and reached the lowest/peak 10d after treatment. Vs, Vd, and Vm 5 d, 10 d, and 21 d after treatment in the minimally invasive group were significantly higher than those in the conservative group, while PI was significantly lower than that in the conservative group. The hematoma and edema volume after treatment in the two groups was significantly reduced. The hematoma and edema volume at each timing point was significantly lower than that in the conservative group. NIHSS score after treatment in the minimally invasive group was significantly reduced. NIHSS score in the conservative group was elevated first and reduced later, reached the peak 10d after treatment, and at each timing point was higher than that in the minimally invasive group.Conclusions:The early minimally invasive operation can significantly improve the hematoma adjacent blood flow volume in patients with hypertensive cerebral hemorrhage, and contribute to the neurological function recovery. TCD not only can be applied in the dynamic monitoring of cerebral blood flow volume in patients with hypertensive cerebral hemorrhage, but also has a certain value in evaluating the prognosis of neurological function. 展开更多
关键词 hypertensive cerebral hemorrhage MINIMALLY invasive intracranial HEMATOMA EVACUATION TCD NIHSS score
下载PDF
Function prognosis promotion and relative factor analysis of subhypothermia therapy to hypertension cerebral hemorrhage patients
6
作者 张银清 陈汉民 +1 位作者 廖圣芳 余锦刚 《中国临床康复》 CSCD 2002年第20期3136-3136,共1页
Objective To study the effect of sub-hypotherm ia on hypertension cerebral hemorrh age and content of serum endothelin(ET).Method87hypertension cerebral hemorrhage cases were divided into subhypothermia group and cont... Objective To study the effect of sub-hypotherm ia on hypertension cerebral hemorrh age and content of serum endothelin(ET).Method87hypertension cerebral hemorrhage cases were divided into subhypothermia group and control group randoml y,patients in subhy-pothermia group received subhypoth ermia therapy in NICU 6hours after operation or hospitalization.We tested serum ET content with specific radioimmunoassay method 24hours,72hours and 3weeks after therapy,and compared them with control group.Result ET content of two groups increased apparently after 24hours,ET of subhypothermia group was lower than that of control group(P <0.01);it recovered 3weeks after therapy.Conclusion Subhypothermia techniques can appa rently improve prognosis of hyperte nsion cerebral hemorrhage patients,serum ET level may be one important index to evaluate severity of hypertension cerebral hemorrhage. 展开更多
关键词 高血压脑出血 亚低温治疗 预后 相关因素分析
下载PDF
肝纤维化与急性缺血性脑卒中患者血管内治疗后发生sICH的相关性
7
作者 吕华东 蓝瑞芳 +1 位作者 陈强棠 劳小芳 《广西医学》 CAS 2024年第7期1002-1006,共5页
目的 探讨肝纤维化与急性缺血性脑卒中(AIS)患者血管内治疗后发生症状性颅内出血(sICH)的相关性。方法 选取80例AIS患者作为研究对象,根据血管内治疗后是否发生sICH分为sICH组和无sICH组。比较两组患者的临床资料。采用多因素Logistic... 目的 探讨肝纤维化与急性缺血性脑卒中(AIS)患者血管内治疗后发生症状性颅内出血(sICH)的相关性。方法 选取80例AIS患者作为研究对象,根据血管内治疗后是否发生sICH分为sICH组和无sICH组。比较两组患者的临床资料。采用多因素Logistic回归模型分析AIS患者血管内治疗后发生sICH的危险因素。绘制受试者工作特征(ROC)曲线分析入院时基于4因子的纤维化指数(FIB-4)预测sICH的效能。结果 血管内治疗术后36 h内,15例(18.75%)患者发生sICH。sICH组和非sICH患者的年龄、入院时美国国立卫生研究院卒中量表(NIHSS)评分、入院时FIB-4比较,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,入院时NIHSS评分较高、入院时FIB-4较高、高龄为AIS患者血管内治疗后发生sICH的危险因素(P<0.05)。ROC曲线分析结果显示,入院时FIB-4预测AIS患者血管内治疗后sICH的曲线下面积为0.815。结论 入院时FIB-4与AIS患者血管内治疗后发生sICH有关,其可作为sICH的预测因子。 展开更多
关键词 急性缺血性脑卒中 血管内治疗 症状性颅内出血 肝纤维化 相关性
下载PDF
有高血压脑出血史的患者冠状动脉介入术标准双抗治疗预后影响因素分析
8
作者 乔曼丽 马立萍 余英 《心肺血管病杂志》 CAS 2024年第2期116-122,共7页
目的:心脏支架置入术后要求使用双重抗血小板治疗(dual antiplatelet therapy DAPT),而脑出血后使用抗血小板治疗仍然存在争议。本研究旨在评估有高血压脑出血病史者,对使用双重抗血小板(双抗)治疗的经皮冠状动脉介入(percutaneous coro... 目的:心脏支架置入术后要求使用双重抗血小板治疗(dual antiplatelet therapy DAPT),而脑出血后使用抗血小板治疗仍然存在争议。本研究旨在评估有高血压脑出血病史者,对使用双重抗血小板(双抗)治疗的经皮冠状动脉介入(percutaneous coronary intervention PCI)术后患者预后的影响。方法:本研究为观察性临床研究,纳入有高血压脑出血病史的PCI患者128例作为观察组,有高血压但无脑出血病史的PCI患者153例作为对照者。所有患者在PCI术后均服用阿司匹林100mg和氯吡格雷75mg治疗,随访时间为12~48个月。疗效结局为主要不良心脑血管病事件,安全性结局为再发脑出血和主要出血。结果:共随访到228例患者,其中观察组102例,对照组126例。既往脑出血病史(HR:1.998,95%CI:1.164~3.415,P=0.012)和冠心病病史(HR:2.664,95%CI:1.388~5.111,P=0.003)是导致高血压的PCI患者,双抗治疗下主要不良心脑血管病事件的危险因素。既往脑出血病史并未增加高血压的PCI患者,双抗治疗下再发脑出血(HR:2.292,95%CI:0.368~14.254,P=0.199)和主要出血的风险(HR:1.467,95%CI:0.475~4.536,P=0.506)。结论:脑出血病史和冠心病病史,是高血压的PCI患者双抗治疗下主要不良心脑血管病事件的危险因素。脑出血病史的高血压患者,PCI术后,在标准双抗治疗下,再发脑出血和主要出血的风险未增加,但明显增加主要不良心脑血管病事件的风险,需予以关注。 展开更多
关键词 冠心病 冠状动脉介入 高血压脑出血 双重抗血小板治疗
下载PDF
既往高血压脑出血经皮冠状动脉介入治疗患者延长双联抗血小板治疗的预后研究
9
作者 乔曼丽 马立萍 +1 位作者 苏崇弘 温雪 《中国医药》 2024年第6期801-805,共5页
目的探讨既往高血压脑出血经皮冠状动脉介入(PCI)治疗患者延长双联抗血小板治疗(DAPT)的风险和获益。方法本研究为观察性临床研究,纳入2005年1月至2014年12月于首都医科大学附属北京安贞医院住院有高血压脑出血病史的PCI患者128例作为... 目的探讨既往高血压脑出血经皮冠状动脉介入(PCI)治疗患者延长双联抗血小板治疗(DAPT)的风险和获益。方法本研究为观察性临床研究,纳入2005年1月至2014年12月于首都医科大学附属北京安贞医院住院有高血压脑出血病史的PCI患者128例作为观察组,有高血压但无脑出血病史的PCI患者153例作为对照组。所有患者PCI术后均服用阿司匹林100 mg/d和氯吡格雷75 mg/d治疗,随访时间为12~48个月。疗效终点为主要不良心脑血管事件(MACCE),安全性终点为脑出血和主要出血。DAPT时间>12个月为延长DAPT,DAPT时间≤12个月为未延长DAPT。对影响终点事件的因素进行单因素及多因素Cox回归分析。结果既往高血压脑出血病史(P=0.029)、急性心肌梗死(P=0.027)是高血压PCI患者MACCE的独立危险因素,而延长DAPT是其独立保护因素(风险比=0.351,P<0.001)。亚组分析中,延长DAPT增加既往高血压脑出血PCI患者主要出血风险(风险比=6.650,P=0.036),但未降低MACCE风险(P=0.349)。延长DAPT未增加既往高血压PCI患者主要出血风险(P=0.538),但能明显降低MACCE风险(风险比=0.356,P=0.044)。结论延长DAPT增加既往高血压脑出血病史的PCI患者主要出血风险,DAPT需控制在12个月之内。延长DAPT在降低既往高血压PCI患者MACCE风险的同时,没有增加其主要出血的风险,建议适当延长DAPT时间。 展开更多
关键词 高血压脑出血 经皮冠状动脉介入 主要出血 双联抗血小板治疗
下载PDF
The effect of hematoma puncture drainage before decompressive craniectomy on the prognosis of hypertensive intracerebral hemorrhage with cerebral hernia at a high altitude 被引量:15
10
作者 Lin-Jie Wei Chi Lin +9 位作者 Xing-Sen Xue Guo-Dong Dun Jian-Bo Zhang Yan-Xiang Tong Jia-Xiong Wang Shi-Ji Yang Ling Wang Zhi Chen Hua Feng Gang Zhu 《Chinese Journal of Traumatology》 CAS CSCD 2021年第6期328-332,共5页
Purpose:Rapid decompressive craniectomy(DC)was the most effective method for the treatment of hypertensive intracerebral hemorrhage(HICH)with cerebral hernia,but the mortality and disability rate is still high.We susp... Purpose:Rapid decompressive craniectomy(DC)was the most effective method for the treatment of hypertensive intracerebral hemorrhage(HICH)with cerebral hernia,but the mortality and disability rate is still high.We suspected that hematoma puncture drainage(PD)+DC may improve the therapeutic effect and thus compared the combined surgery with DC alone.Methods:From December 2013 to July 2019,patients with HICH from Linzhi,Tibet and Honghe,Yunnan Province were retrospectively analyzed.The selection criteria were as follows:(1)altitude≥1500 m;(2)HICH patients with cerebral hernia;(3)Glascow coma scale score of 4-8 and time from onset to admission≤3 h;(4)good liver and kidney function;and(5)complete case data.The included patients were divided into DC group and PD+DC group.The patients were followed up for 6 months.The outcome was assessed by Glasgow outcome scale(GOS)score,Kaplan-Meier survival curve and correlation between time from admission to operation and prognosis.A good outcome was defined as independent(GOS score,4-5)and poor outcome defined as dependent(GOS score,3-1).All data analyses were performed using SPSS 19,and comparison between two groups was conducted using separatet-tests or Chi-square tests.Results:A total of 65 patients was included.The age ranged 34-90 years(mean,63.00±14.04 years).Among them,31 patients had the operation of PD+DC,whereas 34 patients underwent DC.The two groups had no significant difference in the basic characteristics.After 6 months of follow-up,in the PD+DC group there were 8 death,4 vegetative state,4 severe disability(GOS score 1-3,poor outcome 51.6%);8 moderate disability,and 7 good recovery(GOS score 4-5,good outcome 48.4%);while in the DC group the result was 15 death,6 vegetative state,5 severe disability(poor outcome 76.5%),4 moderate disability and 4 good recovery(good outcome 23.5%).The GOS score and good outcome were significantly less in DC group than in PD+DC group(Z=-1.993,p=0.046;χ2=4.38,p=0.043).However,there was no significant difference regarding the survival curve between PD+DC group and DC group.The correlation between the time from admission to operation and GOS at 6 months(r=-0.41,R2=0.002,p=0.829)was not significant in the PD+DC group,but significant in the DC group(r=-0.357,R2=0.128,p=0.038).Conclusion:PD+DC treatment can improve the good outcomes better than DC treatment for HICH with cerebral hernia at a high altitude. 展开更多
关键词 intracranial hemorrhage hypertensive High altitude Cerebral hernia Hematoma puncture drainage Decompressive craniectomy
原文传递
大骨瓣渐进与常规减压术救治重症颅脑损伤效果评价
11
作者 陈强 刘锦平 钱忠伟 《青岛大学学报(医学版)》 CAS 2024年第4期574-577,共4页
目的探讨大骨瓣渐进减压术救治重症颅脑损伤病人的效果及其对相关神经因子和炎症因子影响。方法选择2019年1月—2022年12月南通市第三人民医院救治的重症颅脑损伤病人120例为研究对象,随机分为两组,每组60例。研究组实施渐进性骨瓣减压... 目的探讨大骨瓣渐进减压术救治重症颅脑损伤病人的效果及其对相关神经因子和炎症因子影响。方法选择2019年1月—2022年12月南通市第三人民医院救治的重症颅脑损伤病人120例为研究对象,随机分为两组,每组60例。研究组实施渐进性骨瓣减压术,对照组进行常规骨瓣减压术。比较两组病人的治疗效果、美国国立卫生研究院卒中量表(NIHSS)和格拉斯哥昏迷评分法(GCS)评分以及神经功能等指标的差异。结果研究组术后的脑中线位移和不同时间颅内压均显著低于对照组(t=27.706,F=12.135~29.915,P均<0.001);研究组NIHSS评分显著低于对照组,而GCS评分显著高于对照组(t=3.388~7.844,P<0.001)。研究组术后血清肾素、肾上腺素、血管紧张素Ⅱ和去甲肾上腺素等应激反应因子均显著高于对照组(t=4.147~70.340,P<0.001),相关炎症、循环和神经因子均显著低于对照组(t=5.127~9.763,P<0.001)。术后研究组认知功能、躯体功能、社会功能、情绪功能和总评分均显著高于对照组(t=8.226~31.690,P<0.001)。结论采取大骨瓣渐进减压术救治重症颅脑损伤病人临床效果更好,术后炎症和应激反应以及循环与神经功能恢复效果更显著,病人生活质量更高。 展开更多
关键词 颅脑损伤 颅内出血 创伤性 颅内高压 颅骨切开术 治疗结果
下载PDF
电磁导航辅助神经内镜血肿清除术治疗高血压脑出血患者的临床效果
12
作者 杜娟 刘婷婷 陈素杰 《医学临床研究》 CAS 2024年第7期1051-1053,1057,共4页
【目的】探讨电磁导航辅助神经内镜血肿清除术治疗高血压脑出血(HICH)患者的效果及对患者短期预后的影响。【方法】回顾性分析2020年3月至2023年3月本院收治的102例HICH患者的临床资料,根据手术方案不同将其分为观察组(行电磁导航辅助... 【目的】探讨电磁导航辅助神经内镜血肿清除术治疗高血压脑出血(HICH)患者的效果及对患者短期预后的影响。【方法】回顾性分析2020年3月至2023年3月本院收治的102例HICH患者的临床资料,根据手术方案不同将其分为观察组(行电磁导航辅助神经内镜血肿清除术治疗)和对照组(行常规神经内镜血肿清除术治疗),每组51例。比较两组围术期指标、手术前后美国国立卫生研究院卒中量表(NIHSS)评分、改良Rankin量表(mRS)评分、氧化应激指标[氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)]、血管内皮功能指标[血管升压素(AVP)、血管生成素-1(Ang-1)、内皮素(ET)]及并发症发生情况。【结果】观察组术后血肿残余量低于对照组,血肿清除率高于对照组,住院时间短于对照组,差异有统计学意义(P<0.05)。术后1个月、3个月,两组NIHSS、mRS评分低于术前,且观察组低于对照组,差异有统计学意义(P<0.05)。术后1个月,两组血清SOD、GSH-Px水平高于术前,血清MDA水平低于术前,且两组上述指标比较,差异均有统计学意义(P<0.05)。术后1个月,两组血清AVP、Ang-1、ET水平低于术前,且观察组低于对照组,差异有统计学意义(P<0.05)。观察组并发症发生率低于对照组,差异有统计学意义(P<0.05)。【结论】电磁导航辅助神经内镜血肿清除术有助于改善HICH患者神经功能及预后,优化围术期指标,缓解氧化应激状态,改善患者血管内皮功能,降低并发症发生风险。 展开更多
关键词 颅内出血 高血压性/外科学 神经内窥镜检查 血肿/外科学 预后
下载PDF
微创穿刺引流术联合中药保留灌肠治疗急性期高血压脑出血痰热腑实证临床观察
13
作者 孙龙 王革生 高先政 《河北中医》 2024年第2期193-197,共5页
目的 观察微创穿刺引流术联合中药保留灌肠治疗急性期高血压脑出血(HICH)痰热腑实证的临床疗效。方法 将76例急性期HICH痰热腑实证患者按照随机数字表法分为2组,对照组38例予微创穿刺引流术,术后予西医常规治疗,治疗组38例在对照组治疗... 目的 观察微创穿刺引流术联合中药保留灌肠治疗急性期高血压脑出血(HICH)痰热腑实证的临床疗效。方法 将76例急性期HICH痰热腑实证患者按照随机数字表法分为2组,对照组38例予微创穿刺引流术,术后予西医常规治疗,治疗组38例在对照组治疗基础上加用中药保留灌肠。2组均治疗14天。比较2组疗效;比较2组治疗前后美国国立卫生研究院卒中量表评分(NIHSS)、格拉斯哥昏迷评分(GCS);比较2组治疗前后C反应蛋白(CRP)、神经元特异性烯醇化酶(NSE)水平变化;比较2组治疗前后血清促炎因子、抗炎因子水平变化。结果 治疗组总有效率89.47%(34/38),对照组总有效率68.42%(26/38),治疗组疗效优于对照组(P<0.05)。2组治疗后NIHSS评分均较本组治疗前降低(P<0.05),GCS评分均较本组治疗前升高(P<0.05);治疗后治疗组NIHSS评分低于对照组(P<0.05),GCS评分高于对照组(P<0.05)。2组治疗后CRP、NSE水平均较本组治疗前降低(P<0.05),且治疗组降低更明显(P<0.05)。2组治疗后白细胞介素6(IL-6)、IL-17、肿瘤坏死因子α(TNF-α)、干扰素γ(IFN-γ)均较本组治疗前降低(P<0.05),且治疗组降低更明显(P<0.05)。2组治疗后IL-4、IL-10均较本组治疗前升高(P<0.05),且治疗组升高更明显(P<0.05)。结论 微创穿刺引流术联合中药保留灌肠治疗急性期HICH痰热腑实证,可有效改善患者术后症状,降低炎症水平。 展开更多
关键词 高血压 并发症 脑出血 中西医结合疗法
下载PDF
清震汤加减联合微创血肿清除术治疗高血压脑出血临床研究
14
作者 王莉 周翠玲 +1 位作者 麻伟兴 李燕 《新中医》 CAS 2024年第10期30-34,共5页
目的:观察清震汤加减联合微创血肿清除术治疗高血压脑出血的治疗效果。方法:抽取98例高血压脑出血患者为研究对象,按照随机数字表法分为试验组和对照组各49例。对照组行微创血肿清除术,术后给予西医常规治疗,试验组在对照组基础上联合... 目的:观察清震汤加减联合微创血肿清除术治疗高血压脑出血的治疗效果。方法:抽取98例高血压脑出血患者为研究对象,按照随机数字表法分为试验组和对照组各49例。对照组行微创血肿清除术,术后给予西医常规治疗,试验组在对照组基础上联合清震汤加减治疗。比较2组颅内压(ICP)、美国国立卫生院卒中量表(NIHSS)评分与格拉斯哥昏迷指数(GCS),脑水肿体积和持续时间,血清肿瘤坏死因子-α(TNF-α)、神经生长因子(NGF)、基质金属蛋白酶-9(MMP-9)水平及中医证候评分。结果:术前,2组ICP值比较,差异无统计学意义(P>0.05);术后即刻及24 h、72 h、1周,试验组相同时间点的ICP值均低于对照组(P<0.05)。术前,2组NIHSS、GCS指数评分比较,差异无统计学意义(P>0.05);术后14 d,试验组NIHSS评分低于对照组(P<0.05),GCS指数高于对照组(P<0.05)。术后,试验组脑水肿体积、脑水肿持续时间低于对照组,差异有统计学意义(P<0.05)。术前,2组血清TNF-α、MMP-9、NGF水平比较,差异无统计学意义(P>0.05)。术后14 d,2组血清TNF-α、MMP-9水平较术前下降(P<0.05),血清NGF水平较术前上升(P<0.05);且试验组血清TNF-α、MMP-9水平低于对照组(P<0.05),NGF水平高于对照组(P<0.05)。术前,2组半身不遂、口眼歪斜、神志昏蒙等中医证候评分比较,差异无统计学意义(P>0.05);术后14 d,试验组上述各项中医证候评分均低于对照组(P<0.05)。结论:微创血肿清除术联合清震汤加减治疗高血压脑出血可降低ICP,减轻卒中症状和昏迷指数,减轻脑水肿,改善中医证候及炎症反应。 展开更多
关键词 高血压脑出血 微创血肿清除术 清震汤 颅内压 脑水肿 炎症因子
下载PDF
新型简易徒手锥颅血肿引流术治疗高血压脑出血疗效分析
15
作者 韩若东 张亚飞 +2 位作者 颜秀侠 李博文 钱贝丽 《中国现代神经疾病杂志》 CAS 北大核心 2024年第6期461-470,共10页
目的探讨新型简易徒手锥颅血肿引流术治疗高血压脑出血的疗效。方法共纳入2021年1月至2022年12月安徽医科大学附属亳州医院收治的103例高血压脑出血患者,分别行传统锥颅血肿引流术(传统锥颅组,51例)和新型锥颅血肿引流术(新型锥颅组,52... 目的探讨新型简易徒手锥颅血肿引流术治疗高血压脑出血的疗效。方法共纳入2021年1月至2022年12月安徽医科大学附属亳州医院收治的103例高血压脑出血患者,分别行传统锥颅血肿引流术(传统锥颅组,51例)和新型锥颅血肿引流术(新型锥颅组,52例)。根据手术前后头部CT图像计算血肿清除率,评价引流管置入精准度;采用美国国立卫生研究院卒中量表(NIHSS)评价神经功能缺损程度,改良Rankin量表(mRS)评价神经功能预后。结果新型锥颅组血肿清除率[(45.54±24.23)%对(35.08±6.49)%;t=3.008,P=0.004]和引流管置入精准度[90.38%(47/52)对68.63%(35/51);χ2=7.509,P=0.006]均高于传统锥颅组。新型锥颅组与传统锥颅组血肿量(F=9.157,P=0.003)和mRS评分(F=4.412,P=0.038)差异具有统计学意义,术后新型锥颅组血肿量(t=⁃4.625,P=0.000)和mRS评分(t=⁃2.712,P=0.008)均低于传统锥颅组;两组手术前后血肿量(F=280.635,P=0.000)、NIHSS评分(F=443.320,P=0.000)和mRS评分(F=552.781,P=0.000)差异亦具有统计学意义,新型锥颅组和传统锥颅组术后血肿量(t=10.233,P=0.000;t=19.906,P=0.000)、NIHSS评分(t=14.576,P=0.000;t=15.286,P=0.000)和mRS评分(t=20.201,P=0.000;t=13.511,P=0.000)均低于术前。结论新型简易徒手锥颅血肿引流术治疗高血压脑出血安全、有效。 展开更多
关键词 颅内出血 高血压性 血肿 引流术 体层摄影术 螺旋计算机 神经外科手术
下载PDF
立体定向仪联合颅内血肿清除术对高血压脑出血患者术后并发症及神经功能的影响
16
作者 李月芳 高琳 《中国医药指南》 2024年第24期83-85,共3页
目的探究立体定向仪联合颅内血肿清除术对高血压脑出血患者术后并发症及神经功能的影响。方法选取2023年1月至2024年1月本院收治的80例高血压脑出血患者作为研究对象,采用随机数字表法分为对照组和试验组,各40例,对两组患者的均开展颅... 目的探究立体定向仪联合颅内血肿清除术对高血压脑出血患者术后并发症及神经功能的影响。方法选取2023年1月至2024年1月本院收治的80例高血压脑出血患者作为研究对象,采用随机数字表法分为对照组和试验组,各40例,对两组患者的均开展颅内血肿清除术,其中对照组采用简易定位颅内血肿清除术,试验组采用立体定向下颅内血肿清除术,对比两组患者的相关临床指标。结果试验组患者的神经功能、日常生活评分及手术指标均优于对照组(P<0.05);试验组炎性因子水平指标及并发症发生率均低于对照组(P<0.05)。结论通过立体定向仪结合颅内血肿清除术的方式能够有效改善患者的神经功能,让患者的术后并发症得到减少,有效保障患者的预后水平。 展开更多
关键词 高血压脑出血 立体定向仪 颅内血肿清除术 术后并发症 神经功能
下载PDF
经鼻高流量氧疗气道护理在高血压脑出血术后肺部感染中的应用
17
作者 钟秀英 李文慧 +2 位作者 曾玉鸿 袁婷 吴俊 《临床医药实践》 2024年第5期382-386,共5页
目的:探讨加温加湿经鼻高流量氧疗气道护理联合乙酰半胱氨酸雾化吸入在高血压脑出血术后肺部感染中的应用效果。方法:选择2022年10月—2023年5月收治的62例高血压脑出血术后非机械通气患者,随机分为对照组和观察组,每组31例。对照组采... 目的:探讨加温加湿经鼻高流量氧疗气道护理联合乙酰半胱氨酸雾化吸入在高血压脑出血术后肺部感染中的应用效果。方法:选择2022年10月—2023年5月收治的62例高血压脑出血术后非机械通气患者,随机分为对照组和观察组,每组31例。对照组采用氧驱面罩雾化器气道湿化护理联合乙酰半胱氨酸雾化吸入治疗,观察组采用加温加湿经鼻高流量氧疗气道护理联合乙酰半胱氨酸雾化吸入治疗。比较两组血气指标、气道阻力(Raw)、痰液黏稠度、气道湿化评分与舒适度评分,统计两组不良反应发生情况以及总满意度。结果:干预后两组动脉血二氧化碳分压(PaCO_(2))、Raw低于干预前,且观察组低于对照组(P<0.05)。干预后两组动脉血氧分压(PaO_(2))及血氧饱和度(SaO_(2))高于干预前,且观察组高于对照组(P<0.05)。干预后观察组痰液黏稠度情况优于对照组(P<0.05)。观察组气道湿化评分、舒适度评分及并发症总发生率低于对照组(P<0.05)。观察组满意度高于对照组(P<0.05)。结论:乙酰半胱氨酸雾化吸入联合加温加湿经鼻高流量氧疗气道护理可明显改善高血压脑出血术后肺部感染患者血气指标,降低痰液黏稠度,患者舒适度更高,不良反应更少,满意度更高。 展开更多
关键词 加温加湿经鼻高流量氧疗 乙酰半胱氨酸雾化吸入 高血压脑出血 肺部感染 血气指标 痰液黏稠度 气道湿化评分
下载PDF
高血压性脑出血患者围术期血清炎性因子水平纵向分析及其与预后的相关性
18
作者 刘晶 王瑾 +2 位作者 刘文艳 蔡新旺 徐翔 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第8期902-905,共4页
目的对高血压性脑出血患者围术期血清炎性因子水平进行纵向分析,并探讨其与预后的相关性。方法连续纳入2021年2月至2023年1月唐山市工人医院收治的173例高血压性脑出血患者,分别于术前、术后6、12、24、48、72 h测量患者血清炎性因子水... 目的对高血压性脑出血患者围术期血清炎性因子水平进行纵向分析,并探讨其与预后的相关性。方法连续纳入2021年2月至2023年1月唐山市工人医院收治的173例高血压性脑出血患者,分别于术前、术后6、12、24、48、72 h测量患者血清炎性因子水平,随访6个月,记录患者预后情况,并根据患者预后情况分为预后良好组116例和预后不良组57例,采用多因素logistic回归分析围术期高血压性脑出血患者血清炎性因子水平与预后的相关性。结果高血压性脑出血患者白细胞介素(interleukin,IL)6、IL-1β在术后的72 h内持续增高,肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)水平在术后48 h达到峰值;预后不良组出血至入院时间[(6.32±1.50)h vs(5.14±2.00)h]、血肿量[35.50(24.50,46.00)ml vs 30.00(21.00,41.50)ml]、破入脑室(28.07%vs 2.59%)比例显著高于预后良好组,入院时格拉斯哥昏迷评分[(10.07±1.32)分vs(11.00±0.85)分]显著低于预后良好组,差异有统计学意义(P<0.05,P<0.01)。多因素logistic回归分析显示,术后不同时间点IL-6、IL-1β、TNF-α水平均是高血压性脑出血患者预后不良的独立影响因素(P<0.05,P<0.01)。结论高血压性脑出血患者围术期血清炎性因子IL-6、IL-1β、TNF-α均升高,且不同时间的IL-6、IL-1β、TNF-α水平升高均与高血压性脑出血患者术后6个月内不良预后风险升高相关。 展开更多
关键词 颅内出血 高血压性 围手术期 白细胞介素6 肿瘤坏死因子α 预后 数据相关性
下载PDF
血清Galectin-9和PD-L1蛋白水平与高血压脑出血病人病情严重程度及预后的相关性分析
19
作者 谭林 王成中 《安徽医药》 CAS 2024年第10期2069-2072,共4页
目的探讨血清半乳糖凝集素-9(Galectin-9)和抗程序性死亡因子配体1(PD-L1)蛋白水平与高血压脑出血病人病情严重程度及预后的相关性。方法纳入2020年1月至2022年1月恩施土家族苗族自治州中心医院所收治的117例高血压脑出血病人作为研究对... 目的探讨血清半乳糖凝集素-9(Galectin-9)和抗程序性死亡因子配体1(PD-L1)蛋白水平与高血压脑出血病人病情严重程度及预后的相关性。方法纳入2020年1月至2022年1月恩施土家族苗族自治州中心医院所收治的117例高血压脑出血病人作为研究对象,根据病人病情严重程度将其分为将分为轻型组(41例),中型组(54例)以及重型组(22例),并根据病人的预后状态将其分为预后良好组(76例)和预后不良组(41例)。采用酶联免疫吸附测定检测病人血清中Galectin-9,PD-L1的表达水平;采用logistic回归分析与高血压脑出血病人预后状态有关的影响因素;采用受试者操作特征曲线(ROC曲线)分析Galectin-9、PD-L1对高血压脑出血病人预后状态的预测价值。结果血清Galectin-9水平随病情严重程度的增加而升高,而血清PD-L1水平则随病情严重程度的增加逐渐降低(P<0.05);预后良好组病人血清Galectin-9水平(12.38±2.97)ng/L低于预后不良组(18.46±5.86)ng/L,而血清PD-L1水平(68.19±11.88)mg/L则高于预后不良组(53.23±9.76)mg/L(P<0.05);预后不良组中出血量≥30 mL、出血破入脑室以及美国国立卫生研究院卒中量表(NIHSS)评分≥20分的病人所占比例均高于预后良好组(P<0.05);出血量≥30 mL、出血破入脑室、NIHSS评分≥20分及Galectin-9≥15 ng/L均为高血压脑出血病人预后不良的危险因素,而PD-L1≥60 mg/L则为保护因素;血清Galectin-9和PD-L1预测高血压脑出血病人预后的曲线下面积(AUC)分别为0.88、0.82,二者联合预测的AUC为0.94,优于血清Galectin-9、PD-L1各自单独预测(Z_(二者联合-Galectin-9)=2.21、Z_(二者联合-PD-L1)=1.98,P=0.022、0.047)。结论血清Galectin-9和PD-L1表达水平与高血压脑出血病人病情严重程度密切相关,二者联合检测对病人的预后具有较好的预测效能。 展开更多
关键词 颅内出血 高血压性 半乳糖凝集素-9 抗程序性死亡因子配体1 严重程度 预后
下载PDF
超声辅助神经内镜经侧裂入路治疗基底节区高血压脑出血的手术疗效及安全性
20
作者 高崇丽 陆芳萍 《临床和实验医学杂志》 2024年第1期45-49,共5页
目的探究超声辅助神经内镜经侧裂入路治疗基底节区高血压性脑出血的手术疗效及安全性。方法采用回顾性研究方法分析2020年8月至2022年7月在中国医科大学附属第一医院接受治疗的90例基底节区高血压脑出血患者,按治疗方案不同分为观察组... 目的探究超声辅助神经内镜经侧裂入路治疗基底节区高血压性脑出血的手术疗效及安全性。方法采用回顾性研究方法分析2020年8月至2022年7月在中国医科大学附属第一医院接受治疗的90例基底节区高血压脑出血患者,按治疗方案不同分为观察组和对照组,每组各45例。观察组在超声辅助神经内镜下经侧裂入路治疗,对照组予以经侧裂入路传统小骨窗开颅血肿清除术治疗。比较两组患者的血肿清除率、术中及术后情况、格拉斯哥昏迷量表(GCS)评分、术后并发症发生情况、美国国立卫生研究院卒中量表(NIHSS)评分及日常生活活动能力(ADL)评分。结果观察组患者的血肿清除率为(92.25±2.17)%,明显高于对照组[(83.07±2.55)%],差异有统计学意义(P<0.05)。观察组患者的术中失血量、手术时间、术后血肿残余量、住院时间分别为(92.75±18.96)mL、(95.08±17.58)min、(3.72±0.82)mL、(9.27±1.22)d,均分别低于对照组[(311.68±37.87)mL、(179.29±16.73)min、(8.57±1.69)mL、(14.85±1.59)d],差异均有统计学意义(P<0.05)。观察组患者术后7、15、30 d的GCS分别为(9.62±1.09)、(11.57±1.23)、(13.71±1.57)分,分别高于对照组[(8.98±1.12)、(9.63±1.31)、(11.85±1.63)分],差异均有统计学意义(P<0.05)。观察组患者术后并发症发生率为11.11%,明显低于对照组(28.89%),差异有统计学意义(P<0.05)。观察组患者术后NIHSS评分为(9.85±0.87)分,明显低于对照组[(13.87±0.92)分],术后ADL评分为(66.71±4.78)分,明显高于对照组[(51.23±4.93)分],差异均有统计学意义(P<0.05)。结论经超声辅助神经内镜经侧裂入路治疗基底节区高血压性脑出血可获得满意的血肿清除率,能改善患者意识障碍程度,并促进神经功能恢复,提高患者生活质量,还可缩短手术时间和住院时间,减少术中失血量和后血肿残余量,且治疗安全性较高。 展开更多
关键词 颅内出血 高血压性 超声引导 神经内镜 经侧裂入路 血肿清除术 手术疗效 安全性
下载PDF
上一页 1 2 67 下一页 到第
使用帮助 返回顶部